Sponsor Dossier
AstraZeneca
Sponsor Dossier for AstraZeneca. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ANDEXXA
- Brand: ARIMIDEX
- Brand: ARX-Ticagrelor
- Brand: BETALOC
- Brand: BEVESPI
- Brand: BREZTRI AEROSPHERE
- Brand: BRICANYL
- Brand: BRILINTA
About
AstraZeneca is an Australian Private Company with ABN 54009682311, registered in NSW and currently active. The company operates under several trading names including FOCUS PHARMACEUTICALS and STUART PHARMACEUTICALS.
Portfolio
AstraZeneca has 46 brands on the ARTG, of which 42 are indexable and 40 carry a Product Information document. 29 brands are PBS-listed, 21 have a PBAC outcome on record, and 21 have an AusPAR on record. Notable brands include ANDEXXA, ARIMIDEX, ARX-Ticagrelor, BETALOC, BEVESPI, BREZTRI AEROSPHERE, BRICANYL, BRILINTA, CALQUENCE, COSUDEX, DAPAGLIFLOZIN, DATROWAY.
Therapeutic focus
— Oncology: 14 brands — Respiratory: 9 brands — Endocrinology: 7 brands — Cardiology: 6 brands — Gastroenterology: 3 brands — Infectious Disease: 2 brands — Immunology: 2 brands — Renal: 1 brand — Haematology: 1 brand — Rare Disease: 1 brand
PBS footprint
29 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-09-01, across 21 brands with a PBAC outcome on record. The latest AusPAR is 2026-10-20, across 21 brands with an AusPAR on record.